• Please log in or register to access this feature.
You have free access to this content

The first postmodern pandemic: 25 years of HIV/ AIDS

  1. L. O. Kallings

Article first published online: 17 JAN 2008

DOI: 10.1111/j.1365-2796.2007.01910.x

Issue

Journal of Internal Medicine

Journal of Internal Medicine

Volume 263, Issue 3, pages 218–243, March 2008

Additional Information

How to Cite

Kallings, L. O. (2008), The first postmodern pandemic: 25 years of HIV/ AIDS. Journal of Internal Medicine, 263: 218–243. doi: 10.1111/j.1365-2796.2007.01910.x

Author Information

  1. MD, Professor Emeritus, Clinical Microbiology, Former Secretary-General of the International AIDS Society

*Prof. Lars O. Kallings MD, PhD, Alevägen 4, SE-182 67 Djursholm, Sweden. (fax: +46 (0)8 755 3060; e-mail: l.kallings@telia.com).

  1. Disclaimer: The author wrote this review as an independent scientist. Its content does not necessarily represent the views of any organization to which the author is, or has been, affiliated. The author is Founding President of the International AIDS Society (IAS) and was its Secretary-General 1994–2002.

Publication History

  1. Issue published online: 17 JAN 2008
  2. Article first published online: 17 JAN 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (982K)

References

  • 1
    Jarrett WF. Experimental studies of feline and bovine leukemia. Proc R Soc Med 1966; 59: 661–2.
  • 2
    Jarrett W, Jarrett O, Mackey L, Laird H, Hardy Jr W, Essex M. Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst 1973; 51: 833–41.
  • 3
    Essex ME. Feline leukemia: a naturally occurring cancer of infectious origin. Epidemiol Rev 1982; 4: 189–203.
  • 4
    Huebner RJ, Todaro GJ. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A 1969; 64: 1087–94.
  • 5
    Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860–921.
  • 6
    Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980; 77: 7415–9.
  • 7
    Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571–3.
  • 8
    Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies of the antigen in human sera. Proc Natl Acad Sci U S A 1981; 78: 6476–80.
  • 9
    Robert-Guroff M, Kalyanaraman VS, Blattner WA et al. Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients. J Exp Med 1983; 157: 248–58.
  • 10
    De-Thé G, Gessain A, Gazzolo L et al. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. Cancer Res 1985; 45(9 Suppl.): 4633s–6s.
  • 11
    Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970; 226: 1211–3.
  • 12
    Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970; 226: 1209–11.
  • 13
    Morgan DA, Ruscetti FW, Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976; 193: 1007–8.
  • 14
    Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224: 497–500.
  • 15
    Gallo RC. Historical essay. The early years of HIV/AIDS. Science 2002; 298: 1728–30.
  • 16
    Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868–71.
  • 17
    Prusiner SB. Historical essay. Discovering the cause of AIDS. Science 2002; 298: 1726.
  • 18
    Montagnier L. Historical essay. A history of HIV discovery. Science 2002; 298: 1727–8.
  • 19
    Coffin J, Haase A, Levy JA et al. Human immunodeficiency viruses. Science 1986; 232: 697.
  • 20
    Downing RG, Eglin RP, Bayley AC. African Kaposi’s sarcoma and AIDS. Lancet 1984; 1: 478–80.
  • 21
    Bayley AC. Aggressive Kaposi’s sarcoma in Zambia, 1983. Lancet 1984; 1: 1318–20.
  • 22
    Stekler J, Coombs RW. Transmitted HIV-1 drug resistance: are we seeing just the tip of an epidemiological iceberg? J Infect Dis 2007; 196: 336–8. Epub 2007 Jun 19.
  • 23
    Joint United Nations Programme on HIV/AIDS (UNAIDS). 2006 Report on the Global AIDS Epidemic. A UNAIDS 10th Anniversary Special Edition. UNAIDS: Geneva, Switzerland, 2006.
  • 24
    WHO/UNAIDS. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. WHO/UNAIDS: Montreaux, 2007.
  • 25
    Korber B, Muldoon M, Theiler J et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000; 288: 1789–96.
  • 26
    Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287: 607–14.
  • 27
    Williams G, Stretton TB, Leonard JC. Cytomegalic inclusion disease and Pneumocystis carinii infection in an adult. Lancet 1960; 2: 951–5.
  • 28
    Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998; 391: 594–7.
  • 29
    Van de Perre P, Rouvroy D, Lepage P et al. Acquired immunodeficiency syndrome in Rwanda. Lancet 1984; 2: 62–5.
  • 30
    Van de Perre P, Le Polain B, Carael M, Nzaramba D, Zissis G, Butzler JP. HIV antibodies in a remote rural area in Rwanda, Central Africa: an analysis of potential risk factors for HIV seropositivity. AIDS 1987; 1: 213–5.
  • 31
    Centers for Disease Control (CDC). Pneumocystis pneumonia – Los Angeles. MMWR 1981; 30: 250–2.
  • 32
    CDC. Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. MMWR 1981; 30: 305–8.
  • 33
    Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A. 2007; 104: 18566–70.
  • 34
    Dorrington RE, Johnson LF, Bradshaw D, Daniel T. The Demographic Impact of HIV/AIDS in South Africa. National and Provincial Indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Council and Actuarial Society of South Africa. 2006.
  • 35
    Caraël M, Holmes KK. Dynamics of HIV epidemics in sub-Saharan Africa: introduction. AIDS 2001; 15(Suppl. 4): S1–4.
  • 36
    Ferry B, Caraël M, Buvé A et al. Study Group on Heterogeneity of HIV Epidemics in African Cities. Comparison of key parameters of sexual behaviour in four African urban populations with different levels of HIV infection. AIDS 2001; 15(Suppl. 4): S41–50.
  • 37
    Carael M, Glynn R, Lagarde E, Morison L. Sexual networks and HIV in four African populations. In: MMorris, ed Network Epidemiology. Oxford: Oxford University Press, 2004; 58–84.
  • 38
    Halperin DT, Epstein H. Concurrent sexual partnerships help to explain Africa’s high HIV prevalence: implications for prevention. Lancet 2004; 364: 4–6.
  • 39
    UNAIDS. Financial Resources Required to Achieve Universal Access to HIV Prevention, Treatment, Care and Support. UNAIDS: Geneva, 2007.
  • 40
    World Bank warning. AIDS to cause complete economic collapse within 3 generations. S Afr Med J 2003; 93: 745–6.
  • 41
    Duesberg P, Koehnlein C, Rasnick D. The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition. J Biosci 2003; 28: 383–412.
  • 42
    [No author listed]. The Durban Declaration. Nature 2000; 406: 15–6.
  • 43
    Brown AE, McNeil JG. HIV vaccine development: a subtype E-specific strategy. Southeast Asian J Trop Med Public Health 1998; 29: 377–82.
  • 44
    Anderson JP, Rodrigo AG, Learn GH et al. Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. J Virol 2000; 74: 10 752–65.
  • 45
    Abecasis AB, Lemey P, Vidal N et al. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. J Virol 2007; 81: 8543–51.
View Full Article (HTML) Get PDF (982K)